IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL. (October 2022) - Alexander, S.; Aupérin, A.; Bomken, S.; Csoka, M.; Kazanowska, B.; Chiang, A.; Moreno, M. Andrés; Uyttebroeck, A.; Burke, A.; Zsiros, J.; Pillon, M.; Bollard, C.; et al.